Idera Pharmaceuticals Inc (IDRA)
1.03
-0.02 -1.90%
NASDAQ
Jul 30, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -3.56 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -5.741M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 51.53M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | -- |
| PE Ratio | -- |
| Price to Book Value | 1.218 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -9.591M |
| Return on Equity | Upgrade |
View All IDRA News
News
-
WireHeadlineTime (ET)
-
PR Newswire06/23 10:45
-
SA Breaking News06/22 11:41
-
SA Breaking News06/22 11:02
-
PR Newswire06/22 09:31
-
SA Breaking News06/22 08:21
-
Yahoo06/05 05:59
-
SA Breaking News06/04 08:21
-
SA Breaking News06/03 16:49
-
SA Breaking News05/19 09:27
-
Yahoo05/19 07:56
-
MT Newswires05/18 16:44
-
Globe Newswire05/18 16:15
-
Globe Newswire04/29 16:10
-
MT Newswires03/19 16:27
-
MT Newswires03/19 16:07
-
MT Newswires03/19 13:30
-
MT Newswires03/19 12:42
-
SA Breaking News03/19 12:42
-
SA Breaking News03/19 12:21
-
SA Breaking News03/19 11:04
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/04/2021 | Earnings Results | Q2 2021 Earnings Results |
| 04/29/2021 | Earnings Results | Q1 2021 Earnings Results |
| 03/01/2021 | Earnings Results | Q4 2020 Earnings Results |
| 10/29/2020 | Earnings Results | Q3 2020 Earnings Results |
| 08/04/2020 | Earnings Results | Q2 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates.
- URL: https://www.iderapharma.com
- Investor Relations URL: http://ir.iderapharma.com/phoenix.zhtml?c=208904&p=irol-irhome
- HQ State/Province: Pennsylvania
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Aug. 04, 2021
- Last Earnings Release: Apr. 29, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 1.03 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- IDRA Tweets Stocktwits
Advertisement
